Becker's Healthcare December 15, 2023
Medtronic’s PulseSelect Pulsed Field Ablation System for the treatment of both paroxysmal and persistent atrial fibrillation has become the first PFA device to earn FDA approval.
“The PulseSelect PFA system, together with the CE Marked Affera mapping and ablation system and our strong Cryo platform, enables us to provide a broad portfolio of solutions to clinicians and their patients, all developed with years of research and supported by compelling scientific evidence,” Rebecca Seidel, senior vice president and president of the Cardiac Ablation Solutions business, said in a Dec. 13 press release.
...Today's Sponsors
Today's Sponsor